CN Patent
CN116529249A — 吡啶并嘧啶酮类化合物
Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2023-08-01 · 3y expired
What this patent protects
一类吡啶并嘧啶酮类化合物,具体涉及式(I)化合物及其药学上可接受的盐,以及式(I)化合物及其药学上可接受的盐在制备治疗相关疾病中的应用。
USPTO Abstract
一类吡啶并嘧啶酮类化合物,具体涉及式(I)化合物及其药学上可接受的盐,以及式(I)化合物及其药学上可接受的盐在制备治疗相关疾病中的应用。
Drugs covered by this patent
- Lumakras (SOTORASIB) · Amgen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.